Crush The Market

undefined Logo

Sorrento Therapeutics, Inc.

1.19 USD

-5.56%

Add To Watchlist

Page 1 of 19

2021-2003

Currency in USD2021
PeriodFY
Revenue52.90 Million
Cost Of Revenue13.03 Million
Gross Profit39.87 Million
Gross Profit Ratio0.75
Research And Development Expenses206.92 Million
General And Administrative Expenses0.00
Selling And Marketing Expenses0.00
Selling General And Administrative Expenses196.86 Million
Other Expenses4.14 Million
Operating Expenses407.92 Million
Cost And Expenses420.95 Million
Interest Income0.00
Interest Expense10.22 Million
Depreciation And Amortization12.46 Million
Ebitda-439.15 Million
Ebitdaratio-8.30
Operating Income-401.45 Million
Operating Income Ratio-7.59
Total Other Income Expenses Net-61.08 Million
Income Before Tax-462.53 Million
Income Before Tax Ratio-8.74
Income Tax Expense-33.52 Million
Net Income-428.32 Million
Net Income Ratio-8.10
Eps-1.45
Epsdiluted-1.45
Weighted Average Shs Out294.77 Million
Weighted Average Shs Out Dil294.77 Million
Linkhttps://www.sec.gov/Archives/edgar/data/850261/000095017022003472/0000950170-22-003472-index.htm
Final Linkhttps://www.sec.gov/Archives/edgar/data/850261/000095017022003472/srne-20211231.htm

Crush The Market

We Use Cookies